Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell Lymphoma

NCT03704298 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped Development program terminated

Conditions

Relapsed/Refractory Large B-cell Lymphoma

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: Axicabtagene Ciloleucel
BIOLOGICAL: Utomilumab

Sponsor

Kite, A Gilead Company

Collaborators

[object Object]